Funded Biotechnology Startups in Dublin
Among the ten most recently funded biotechnology companies tagged to Dublin, nine are headquartered in Dublin, Ireland; the lone exception is DasiSimulatio…
Among the ten most recently funded biotechnology companies tagged to Dublin, nine are headquartered in Dublin, Ireland; the lone exception is DasiSimulations, based in Dublin, Ohio, which raised a $5M Series Unknown round in February 2024. The Irish cluster spans multiple stages: Antler Bio closed a $4M seed in June 2025, and Neuromod Devices raised an $11M Series B in March 2025, making Q1 2025 the most active recent quarter in the set.
Carrick Therapeutics sits at the higher end of disclosed venture rounds at $35M (December 2022), while Beyondbmi represents the smallest disclosed amount at $1M (Seed, December 2023). Perrigo's $2.6B post-IPO debt raise from April 2022 is structurally distinct — it reflects debt capital at a public-company scale rather than venture financing. Series B activity recurs across Impedans ($4M, July 2022), SOMAÍ Pharmaceuticals ($4M, April 2024), and Neuromod Devices ($11M, March 2025), all Dublin, Ireland-based.
Most recent rounds
10 shownRelated listings
Frequently asked
What are the largest disclosed venture rounds among these Dublin biotech companies?
Carrick Therapeutics leads venture-stage rounds at $35M (Series Unknown, December 2022), followed by Neuromod Devices at $11M (Series B, March 2025) and Kastus Technologies at $7M (round type unlisted, June 2021). Perrigo's $2.6B raise is a post-IPO debt instrument and not comparable to the venture rounds in this set.
Which funding stages appear most frequently in this dataset?
Series B and Series Unknown each account for three of the ten companies. Seed rounds appear twice (Antler Bio and Beyondbmi). One company, Kastus Technologies, has no round type listed, and Nemysis disclosed no amount alongside its Series Unknown classification.
Is Dublin, Ireland the primary location, or does this data include other cities named Dublin?
Nine of the ten companies are in Dublin, Ireland. DasiSimulations is the only outlier, located in Dublin, Ohio — it raised a $5M Series Unknown round in February 2024. Sales teams targeting Irish biotech can treat this as an almost entirely Ireland-specific dataset.
Which companies raised Series B rounds, and what were the deal sizes?
Three companies closed Series B rounds: Neuromod Devices ($11M, March 2025), SOMAÍ Pharmaceuticals ($4M, April 2024), and Impedans ($4M, July 2022). All three are based in Dublin, Ireland, and the disclosed amounts cluster tightly between $4M and $11M.
How recent is the funding activity shown for Dublin biotech?
The most recent close is Antler Bio's $4M seed in June 2025. Nemysis and Neuromod Devices both raised in March 2025, suggesting continued deal flow into the first half of 2025. The oldest entry in the set is Kastus Technologies from June 2021.
Are there any companies with undisclosed round amounts that are still worth tracking?
Nemysis raised a Series Unknown round on March 18, 2025 with no disclosed amount — making it a live, recently active target for sales outreach despite limited public financial detail. Kastus Technologies also has no round type listed, though its $7M amount from June 2021 is disclosed.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.